Phase 1 Advanced Malignant Cancer Clinical Trials
4 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–4 of 4 trials
Recruiting
Phase 1
Clinical Trial of TQB3205 Capsule in Subjects With Advanced Malignant Tumors
Advanced Malignant Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.156 enrolled1 locationNCT07482592
Recruiting
Phase 1
A Clinical Trial on the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of TQB3019 Capsule in Subjects With Advanced Malignant Tumors
Advanced Malignant Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.80 enrolled15 locationsNCT06943677
Completed
Phase 1
A Phase 1 Study of Deflexifol in patients with advanced malignancy after failure of standard treatment
Advanced Malignant Cancer
Detsamma Investments Pty Ltd19 enrolled1 locationACTRN12619001533189
Completed
Phase 1
A Phase 1 Study of Infusional or Bolus Deflexifol in patients with advanced malignacy after failure of standard treatment
Advanced Malignant Cancer
FivePhusion30 enrolled1 locationACTRN12618000297224